New therapeutic target identified for acute lung injury

March 18, 2014
This is Dr. Stephen Black, cell and molecular physiologist at the Medical College of Georgia at Georgia Regents University. Credit: Phil Jones

A bacterial infection can throw off the equilibrium between two key proteins in the lungs and put patients at risk for a highly lethal acute lung injury, researchers report.

Bacteria can alter a single amino acid in the protein RhoA, pushing its activity level well above that of Rac1 and prompting blood vessels to leak and flood thousands of tiny air sacs in the lungs, said Dr. Stephen Black, cell and molecular physiologist at the Medical College of Georgia at Georgia Regents University.

The study in The Journal of Biological Chemistry also proposes a biological shield that appears to protect RhoA from the potentially lethal alteration.

"Activation of RhoA appears to be an early, early event and it's a pathologic activation," Black said. "The cell can't regulate it anymore. It just stays on," he said, comparing the aberrant activity level to a rapid-fire gun with no pause for reload.

Causes of include common bacterial infections that cause maladies such as pneumonia; severe trauma that induces shock; multiple transfusions; burns; and meconium aspiration, when newborns inhale waste products. Mechanical ventilation used to support ailing lungs can also cause or compound the problem that occurs in about 150,000 Americans annually, killing about one-third, and leaving many with damaged lungs.

While overactive RhoA was believed to be a culprit, just how it contributed was unknown. Researchers also knew that nitration – adding a nitro group to a protein to change its function – occurs at high rates in acute lung injury and normalizes when the stimulus, such as a bacterium, is removed.

Using human lung cells and mass spectrometry, they found the amino acid Y34 was altered in this condition. Then, using 3-D computer modeling, they mapped out exactly how that alteration affects RhoA function. They found it turns RhoA into a steady-firing protein.

While antibiotics can wipe out the bacterial stimulus, patients must survive long enough for the body to resume making normal RhoA. "This is one of the insidious things. You can clear the and still die," Black said. The good news is that the proteins turn over in just a few days.

Nitration occurs, in this case, when peroxynitrite is added to a protein, a move previously believed lethal to the protein. However, MCG researchers found nitration can also activate RhoA.

Once they found the specific modification, they designed a peptide that mimics the normal protein sequence and placed it on top of the area of nitration. "Think about it as a shield," Black said. For these early experiments, researchers gave the peptide shield before the stimulus to see if they were even on the right track. They've since redesigned the peptide to reduce undesirable effects on normal RhoA signaling and are now giving it the way patients may one day get it: after changes to Y34 already have occurred. "We have high hopes for what we call the gen-2 peptide," said Black, citing early evidence that it can normalize RhoA activity.

Y34 is one of about 200 in RhoA. "We are looking at one amino acid in one protein in an extraordinarily complex disease and it makes it better," said Black.

To ensure tight regulation of the consistency of blood vessel walls, Rac1 and RhoA normally have the opposing functions of pulling together and pushing apart the endothelial cells that line them. "The balance of those determines whether you are going to be tight or leaky," Black said. "If you can clear the stimulus, you can theoretically make the cells knit back together again."

Still unclear is how long RhoA can sustain its bacteria-modified super-pace and whether non-bacterial causes of acute prompt the exact RhoA alteration.

The researchers performed simultaneous studies in an animal model. The research was funded by a National Institutes of Health Program Project grant.

Explore further: Study identifies essential molecule in formation of differentiated blood cells

Related Stories

Study identifies essential molecule in formation of differentiated blood cells

October 7, 2013
New research in the Journal of Experimental Medicine identifies a protein that controls the formation of different types of mature blood cells – a finding that could be important to developing new treatments for blood diseases ...

Better treatment sought for acute lung injury

August 22, 2011
Patients can essentially drown in their own fluids when trauma and infection prompt blood vessels to leak, flooding millions of air sacs in their lungs.

Rock And Rho: Proteins that help cancer cells groove

December 26, 2013
Biologists at The Johns Hopkins University have discovered that low oxygen conditions, which often persist inside tumors, are sufficient to initiate a molecular chain of events that transforms breast cancer cells from being ...

Researchers use new molecular inhibitors to successfully hit difficult cancer target

February 5, 2013
Early laboratory tests are the first to successfully use an experimental molecular therapy to block a hard-to-target part of a protein complex linked to several types of invasive cancer.

Spread of cancer cells may be slowed by targeting of protein

December 18, 2012
(Medical Xpress)—The spread of cancer cells may be slowed by targeting the protein km23-1, according to researchers at Penn State College of Medicine.

Research offers hope in new treatment for spinal cord injuries

May 3, 2011
Rutgers researchers have developed an innovative new treatment that could help minimize nerve damage in spinal cord injuries, promote tissue healing and minimize pain.

Recommended for you

Want to win at sports? Take a cue from these mighty mice

July 20, 2017
As student athletes hit training fields this summer to gain the competitive edge, a new study shows how the experiences of a tiny mouse can put them on the path to winning.

A sodium surprise: Engineers find unexpected result during cardiac research

July 20, 2017
Irregular heartbeat—or arrhythmia—can have sudden and often fatal consequences. A biomedical engineering team at Washington University in St. Louis examining molecular behavior in cardiac tissue recently made a surprising ...

Engineered liver tissue expands after transplant

July 19, 2017
Many diseases, including cirrhosis and hepatitis, can lead to liver failure. More than 17,000 Americans suffering from these diseases are now waiting for liver transplants, but significantly fewer livers are available.

Lunatic Fringe gene plays key role in the renewable brain

July 19, 2017
The discovery that the brain can generate new cells - about 700 new neurons each day - has triggered investigations to uncover how this process is regulated. Researchers at Baylor College of Medicine and Jan and Dan Duncan ...

'Smart' robot technology could give stroke rehab a boost

July 19, 2017
Scientists say they have developed a "smart" robotic harness that might make it easier for people to learn to walk again after a stroke or spinal cord injury.

New animal models for hepatitis C could pave the way for a vaccine

July 19, 2017
They say that an ounce of prevention is worth a pound of cure. In the case of hepatitis C—a disease that affects nearly 71 million people worldwide, causing cirrhosis and liver cancer if left untreated—it might be worth ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.